纳米医学在恶性黑色素瘤诊断和治疗中的应用

doi:10.35541/cjd.20230109

中华皮肤科杂志 ›› 2026, Vol. 59 ›› Issue (2): 189-192.doi: 10.35541/cjd.20230109

• 综述 • 上一篇

纳米医学在恶性黑色素瘤诊断和治疗中的应用

严可心张韡宋昊徐秀莲

中国医学科学院、北京协和医学院皮肤病医院病理科，南京 210042

收稿日期:2023-02-28 修回日期:2023-12-09 发布日期:2026-02-03
通讯作者: 徐秀莲 E-mail:xxlqjl@sina.com
基金资助:
国家自然科学基金（81772916，82103470）；江苏省自然科学基金（BK20171132）

Application of nanomedicine in the diagnosis and treatment of melanoma

Yan Kexin, Zhang Wei, Song Hao, Xu Xiulian

Department of Pathology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences ＆ Peking Union Medical College, Nanjing 210042, China

Received:2023-02-28 Revised:2023-12-09 Published:2026-02-03
Contact: Xu Xiulian E-mail:xxlqjl@sina.com
Supported by:
National Natural Science Foundation of China （81772916, 82103470）; Jiangsu Natural Science Foundation （BK20171132）

摘要/Abstract

摘要： 【摘要】恶性黑色素瘤在皮肤癌中最具侵袭性，其诊断和治疗仍是一个艰巨的挑战。目前，晚期黑色素瘤的治疗方法有免疫治疗、化学疗法、分子靶向治疗、放射治疗、光动力疗法、光热疗法、基因治疗等，但是它们的治疗效果有限。新兴的纳米材料在癌症的诊断和治疗中，能够提高药物的生物利用度，并且精准靶向癌细胞。本文综述用于恶性黑色素瘤的诊断和不同治疗方法中的一些纳米颗粒的最新研究进展。

关键词: 黑色素瘤, 纳米医学, 脂质体, 磁性纳米粒子, 诊断, 治疗

Abstract: 【Abstract】 Melanoma is the most aggressive skin cancers, and its diagnosis and treatment remain a formidable challenge. At present, treatment methods for advanced melanoma include immunotherapy, chemotherapy, molecular targeted therapy, radiotherapy, photodynamic therapy, photothermal therapy, gene therapy, etc., but their efficacy remains limited. Application of emerging nanomaterials in the diagnosis and treatment of cancers can improve the drug bioavailability and cancer cell-targeting precision. This review summarizes the latest research progress on some nanoparticles used for the diagnosis and treatment of melanoma.

Key words: Melanoma, Nanomedicine, Liposomes, Magnetite nanoparticles, Diagnosis, Therapy

严可心张韡宋昊徐秀莲. 纳米医学在恶性黑色素瘤诊断和治疗中的应用[J]. 中华皮肤科杂志, 2026,59(2):189-192. doi:10.35541/cjd.20230109

Yan Kexin, Zhang Wei, Song Hao, Xu Xiulian. Application of nanomedicine in the diagnosis and treatment of melanoma[J]. Chinese Journal of Dermatology, 2026, 59(2): 189-192.doi:10.35541/cjd.20230109

参考文献 46

［1］	Yang K, Oak A, Slominski RM, et al. Current molecular markers of melanoma and treatment targets［J］. Int J Mol Sci, 2020,21（10）:3535. doi: 10.3390/ijms21103535.
［2］	Al⁃Zoubi MS, Al⁃Zoubi RM. Nanomedicine tactics in cancer treatment: challenge and hope［J］. Crit Rev Oncol Hematol, 2022,174:103677. doi: 10.1016/j.critrevonc.2022.103677.
［3］	Peng S, Xiao F, Chen M, et al. Tumor⁃microenvironment⁃responsive nanomedicine for enhanced cancer immunotherapy［J］. Adv Sci （Weinh）, 2022,9（1）:e2103836. doi: 10.1002/advs. 202103836.
［4］	Farjadian F, Ghasemi A, Gohari O, et al. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities［J］. Nanomedicine （Lond）, 2019,14（1）:93⁃126. doi: 10.2217/nnm⁃2018⁃0120.
［5］	Wang P, Yang W, Shen S, et al. Differential diagnosis and precision therapy of two typical malignant cutaneous tumors leveraging their tumor microenvironment: a photomedicine strategy［J］. ACS Nano, 2019,13（10）:11168⁃11180. doi: 10.1021/ acsnano.9b04070.
［6］	Portilho FL, Helal⁃Neto E, Cabezas SS, et al. Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography［J］. Artif Cells Nanomed Biotechnol, 2018,46（sup1）:1080⁃1087. doi: 10.1080/21691401.2018.1443941.
［7］	Zou Y, Wei Y, Sun Y, et al. Cyclic RGD⁃functionalized and disulfide⁃crosslinked iodine⁃rich polymersomes as a robust and smart theranostic agent for targeted CT imaging and chemotherapy of tumor［J］. Theranostics, 2019,9（26）:8061⁃8072. doi: 10.7150/thno.37184.
［8］	Qiu X, Wu X, Fang X, et al. Raman spectroscopy combined with deep learning for rapid detection of melanoma at the single cell level［J］. Spectrochim Acta A Mol Biomol Spectrosc, 2023,286:122029. doi: 10.1016/j.saa.2022.122029.
［9］	Zhang Y, Takahashi Y, Hong SP, et al. High⁃resolution label⁃free 3D mapping of extracellular pH of single living cells［J］. Nat Commun, 2019,10（1）:5610. doi: 10.1038/s41467⁃019⁃13535⁃1.
［10］	Ou YC, Wen X, Johnson CA, et al. Multimodal multiplexed immunoimaging with nanostars to detect multiple immuno⁃markers and monitor response to immunotherapies［J］. ACS Nano, 2020,14（1）:651⁃663. doi: 10.1021/acsnano.9b07326.
［11］	Jenkins RW, Fisher DE. Treatment of advanced melanoma in 2020 and beyond［J］. J Invest Dermatol, 2021,141（1）:23⁃31. doi: 10.1016/j.jid.2020.03.943.
［12］	Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma［J］. Lancet, 2021,398（10304）:1002⁃1014. doi: 10. 1016/S0140⁃6736（21）01206⁃X.
［13］	Yang X, Fan J, Wu Y, et al. Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy［J］. Nanomedicine, 2021,37:102443. doi: 10.1016/j.nano.2021.102443.
［14］	Hu M, Zhang J, Kong L, et al. Immunogenic hybrid nanovesicles of liposomes and tumor⁃derived nanovesicles for cancer immunochemotherapy［J］. ACS Nano, 2021,15（2）:3123⁃3138. doi: 10.1021/acsnano.0c09681.
［15］	Salotto KE, Olson WC Jr, Pollack KE, et al. A nano⁃enhanced vaccine for metastatic melanoma immunotherapy［J］. Cancer Drug Resist, 2022,5（3）:829⁃845. doi: 10.20517/cdr.2021.132.
［16］	Sun Y, Lu D, Yin Y, et al. PTENα functions as an immune suppressor and promotes immune resistance in PTEN⁃mutant cancer［J］. Nat Commun, 2021,12（1）:5147. doi: 10.1038/s41467⁃021⁃25417⁃6.
［17］	Lin YX, Wang Y, Ding J, et al. Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models［J］. Sci Transl Med, 2021,13（599）:eaba9772. doi: 10.1126/scitranslmed.aba9772.
［18］	Christofides A, Strauss L, Yeo A, et al. The complex role of tumor⁃infiltrating macrophages［J］. Nat Immunol, 2022,23（8）:1148⁃1156. doi: 10.1038/s41590⁃022⁃01267⁃2.
［19］	Rao L, Zhao SK, Wen C, et al. Activating macrophage⁃mediated cancer immunotherapy by genetically edited nanoparticles［J］. Adv Mater, 2020,32（47）:e2004853. doi: 10.1002/adma.202004853.
［20］	Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy［J］. Signal Transduct Target Ther, 2021,6（1）:424. doi: 10.1038/s41392⁃021⁃00827⁃6.
［21］	Epshtein Y, Blau R, Pisarevsky E, et al. Polyglutamate⁃based nanoconjugates for image⁃guided surgery and post⁃operative melanoma metastases prevention［J］. Theranostics, 2022,12（14）:6339⁃6362. doi: 10.7150/thno.72941.
［22］	Zhang MJ, Liang MY, Yang SC, et al. Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis［J］. Chem Commun （Camb）, 2023,59（7）:932⁃935. doi: 10.1039/d2cc05498a.
［23］	Pisarevsky E, Blau R, Epshtein Y, et al. Rational design of polyglutamic acid delivering an optimized combination of drugs targeting mutated BRAF and MEK in melanoma［J］. Adv Ther （Weinh）, 2020,3（8）:2000028 ［pii］. doi: 10.1002/adtp.202000028.
［24］	Shinkuma S. Advances in gene therapy and their application to skin diseases: a review［J］. J Dermatol Sci, 2021,103（1）:2⁃9. doi: 10.1016/j.jdermsci.2021.05.004.
［25］	Liu J, Yang L, Yuan X, et al. Targeted nanotherapeutics using LACTB gene therapy against melanoma［J］. Int J Nanomedicine, 2021,16:7697⁃7709. doi: 10.2147/IJN.S331519.
［26］	Ma Y, Lin H, Wang P, et al. A miRNA⁃based gene therapy nanodrug synergistically enhances pro⁃inflammatory antitumor immunity against melanoma［J］. Acta Biomater, 2023,155:538⁃553. doi: 10.1016/j.actbio.2022.11.016.
［27］	Zhang X, Cai A, Gao Y, et al. Treatment of melanoma by nano⁃conjugate⁃delivered wee1 siRNA［J］. Mol Pharm, 2021,18（9）:3387⁃3400. doi: 10.1021/acs.molpharmaceut.1c00316.
［28］	Zhang Z, Xu D, Wang J, et al. Rolling circle amplification⁃based dna nano⁃assembly for targeted drug delivery and gene therapy［J］. Biomacromolecules, 2023,24（1）:439⁃448. doi: 10.1021/acs. biomac.2c01271.
［29］	Zahraie N, Perota G, Dehdari Vais R, et al. Simultaneous chemotherapy/sonodynamic therapy of the melanoma cancer cells using a gold⁃paclitaxel nanostructure［J］. Photodiagnosis Photodyn Ther, 2022,39:102991. doi: 10.1016/j.pdpdt.2022. 102991.
［30］	Bhattarai RS, Bariwal J, Kumar V, et al. pH⁃sensitive nanomedicine of novel tubulin polymerization inhibitor for lung metastatic melanoma［J］. J Control Release, 2022,350:569⁃583. doi: 10.1016/j.jconrel.2022.08.023.
［31］	Li A, Zhao J, Fu J, et al. Recent advances of biomimetic nano⁃systems in the diagnosis and treatment of tumor［J］. Asian J Pharm Sci, 2021,16（2）:161⁃174. doi: 10.1016/j.ajps.2019.08. 001.
［32］	Molinaro R, Martinez JO, Zinger A, et al. Leukocyte⁃mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma［J］. Biomater Sci, 2020,8（1）:333⁃341. doi: 10.1039/c9bm01766f.
［33］	Wu M, Mei T, Lin C, et al. Melanoma cell membrane biomimetic versatile cus nanoprobes for homologous targeting photoacoustic imaging and photothermal chemotherapy［J］. ACS Appl Mater Interfaces, 2020,12（14）:16031⁃16039. doi: 10.1021/acsami. 9b23177.
［34］	Naidoo C, Kruger CA, Abrahamse H. Photodynamic therapy for metastatic melanoma treatment: a review［J］. Technol Cancer Res Treat, 2018,17:15330338 18791795. doi: 10.1177/1533033 818791795.
［35］	Huang X, Mu N, Ding Y, et al. Targeted delivery and enhanced uptake of chemo⁃photodynamic nanomedicine for melanoma treatment［J］. Acta Biomater, 2022,147:356⁃365. doi: 10.1016/j.actbio.2022.05.015.
［36］	Bian Q, Huang L, Xu Y, et al. A facile low⁃dose photosensitizer⁃incorporated dissolving microneedles⁃based composite system for eliciting antitumor immunity and the abscopal effect［J］. ACS Nano, 2021,15（12）:19468⁃19479. doi: 10.1021/acsnano. 1c06225.
［37］	Wang Y, Zhao Z, Liu C, et al. B16 membrane⁃coated vesicles for combined photodynamic therapy and immunotherapy shift immune microenvironment of melanoma［J］. Int J Nanomedicine, 2022,17:855⁃868. doi: 10.2147/IJN.S338488.
［38］	Hou X, Tao Y, Li X, et al. CD44⁃targeting oxygen self⁃sufficient nanoparticles for enhanced photodynamic therapy against malignant melanoma［J］. Int J Nanomedicine, 2020,15:10401⁃10416. doi: 10.2147/IJN.S283515.
［39］	Zhao L, Zhang X, Wang X, et al. Recent advances in selective photothermal therapy of tumor［J］. J Nanobiotechnology, 2021,19（1）:335. doi: 10.1186/s12951⁃021⁃01080⁃3.
［40］	S M, E S, R DV, et al. Phototherapy and sonotherapy of melanoma cancer cells using nanoparticles of selenium⁃polyethylene glycol⁃curcumin as a dual⁃mode sensitizer［J］. J Biomed Phys Eng, 2020,10（5）:597⁃606. doi: 10.31661/jbpe.v0i0.1912⁃1039.
［41］	Soratijahromi E, Mohammadi S, Dehdari Vais R, et al. Photothermal/sonodynamic therapy of melanoma tumor by a gold/manganese dioxide nanocomposite: in vitro and in vivo studies［J］. Photodiagnosis Photodyn Ther, 2020,31:101846. doi: 10. 1016/j.pdpdt.2020.101846.
［42］	Wang S, Ma Z, Shi Z, et al. Chidamide stacked in magnetic polypyrrole nano⁃composites counter thermotolerance and metastasis for visualized cancer photothermal therapy［J］. Drug Deliv, 2022,29（1）:1312⁃1325. doi: 10.1080/10717544.2022. 2068697.
［43］	Heshmati Aghda N, Torres Hurtado S, Abdulsahib SM, et al. Dual photothermal/chemotherapy of melanoma cells with albumin nanoparticles carrying indocyanine green and doxorubicin leads to immunogenic cell death［J］. Macromol Biosci, 2022,22（2）:e2100353. doi: 10.1002/mabi.202100353.
［44］	Baskar R, Lee KA, Yeo R, et al. Cancer and radiation therapy: current advances and future directions［J］. Int J Med Sci, 2012,9（3）:193⁃199. doi: 10.7150/ijms.3635.
［45］	Chen MH, Lee CH, Liang HK, et al. Integrating the microneedles with carboplatin to facilitate the therapeutic effect of radiotherapy for skin cancers［J］. Biomater Adv, 2022,141:213113. doi: 10.1016/j.bioadv.2022.213113.
［46］	Chan L, Gao P, Zhou W, et al. Sequentially triggered delivery system of black phosphorus quantum dots with surface charge⁃switching ability for precise tumor radiosensitization［J］. ACS Nano, 2018,12（12）:12401⁃12415. doi: 10.1021/acsnano.8b06483.

[1]	许国康蔡梅. 索立德吉治疗局部晚期基底细胞癌8例临床分析[J]. 中华皮肤科杂志, 2026, 59(2): 166-169.
[2]	郝峰左墨范尊卿谢凯王红蕾王学庆陈声利陈学超刘国艳. 光学相干断层扫描技术辅助基底细胞癌诊断的临床研究[J]. 中华皮肤科杂志, 2026, 59(2): 155-160.
[3]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. [开放获取] 中国皮炎湿疹类疾病诊疗指南（2026版）[J]. 中华皮肤科杂志, 2026, 59(2): 97-106.
[4]	陈浩. 几种新的皮肤软组织肿瘤及亚型的临床组织学特点[J]. 中华皮肤科杂志, 2026, 59(2): 120-126.
[5]	黄仁军童星王阿军周乃慧李勇刚. 高分辨率磁共振成像及高频超声在皮肤黑色素瘤术前评估中的应用[J]. 中华皮肤科杂志, 2026, 59(2): 140-146.
[6]	《疥疮诊疗中国专家共识（版）》编写委员会专家组. 疥疮诊疗中国专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(1): 1-8.
[7]	王溯吴晋彤李文钰章程李承新王睿. 低温等离子体治疗小鼠非开放性金黄色葡萄球菌感染性皮肤病的有效性和安全性评价[J]. 中华皮肤科杂志, 2026, 59(1): 44-50.
[8]	项蕾红徐中奕. 真皮获得性斑状色素沉着症的诊疗难点及对策[J]. 中华皮肤科杂志, 2026, 59(1): 74-76.
[9]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会中国中西医结合学会皮肤性病专业委员会中国非公立医疗机构协会皮肤专业委员会. [开放获取] 玫瑰痤疮患者教育指导专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 0(1): 20240725-e20240725.
[10]	刘厚广申宜魏琼玲李峥霍姗姗谢广成刘英文. 过表达或抑制细胞周期蛋白依赖性激酶2对A375细胞代谢组的影响[J]. 中华皮肤科杂志, 2026, 59(1): 51-58.
[11]	陈雁雁张翰林刘莉萍李遇梅. 昼夜节律与黑色素瘤相关性的研究进展[J]. 中华皮肤科杂志, 2026, 59(1): 82-85.
[12]	黄和金李馨雅席文文肖霞蒋斌杨锋. 微创旋切术治疗腋臭患者3 000例术后并发症回顾分析[J]. 中华皮肤科杂志, 2026, 59(1): 62-64.
[13]	周妙妮盛安琪傅丽芳金嵘许文尉晓冬许爱娥. 茶多酚抗氧化凝胶联合窄谱中波紫外线治疗白癜风的疗效及安全性单中心随机对照试验[J]. 中华皮肤科杂志, 2025, 58(9): 834-838.
[14]	徐中奕邢小雪董雅琦张成锋项蕾红. 上海市某三甲医院黄褐斑患者254例临床特征及疗效的回顾性分析[J]. 中华皮肤科杂志, 2025, 58(9): 808-815.
[15]	姜子琪钟菊丹陈廷巧陈瑾. 黄褐斑发病机制及治疗研究进展[J]. 中华皮肤科杂志, 2025, 58(9): 868-872.

纳米医学在恶性黑色素瘤诊断和治疗中的应用

Application of nanomedicine in the diagnosis and treatment of melanoma

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 46

相关文章 15

Metrics

本文评价

推荐阅读 10